2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Motor Activity
13
Colonic Neoplasms
9
Colorectal Neoplasms
8
Neoplasms
7
Rectal Neoplasms
6
Breast Neoplasms
6
Stomach Neoplasms
5
Lung Neoplasms
4
Esophageal Neoplasms
4
Smoking Cessation
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Frailty
3
Urinary Bladder Neoplasms
2
Postoperative Complications
2
Insulin Resistance
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Urologic Neoplasms
1
Smoking
1
Sarcopenia
1
Risk Reduction Behavior
1
Patient Preference
1
Pancreatitis, Chronic
1
Pain
1
Obesity
1
Nutrition Disorders
1
Interventions
Carboplatin
779
Pemetrexed
606
Cisplatin
543
Paclitaxel
490
pembrolizumab
461
Docetaxel
440
Gemcitabine
328
Erlotinib Hydrochloride
307
Radiotherapy
255
Nivolumab
244
Bevacizumab
233
osimertinib
177
Drug Therapy
164
durvalumab
157
atezolizumab
135
Gefitinib
134
Radiosurgery
131
Vinorelbine
111
Cetuximab
97
130-nm albumin-bound paclitaxel
93
Ipilimumab
86
Magnetic Resonance Spectroscopy
83
Taxes
79
Surgical Procedures, Operative
74
Afatinib
68
Albumin-Bound Paclitaxel
66
Specimen Handling
61
Etoposide
61
Cyclophosphamide
60
tislelizumab
59
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
Preoperative Exercise
×
Clear all
NCT07401056
2026-02-12
READY-LUNG
Hacettepe University
Phase NA
Not yet recruiting
62 enrolled
NCT06716437
2025-04-22
DIGI-Lung
University of Melbourne
Phase NA
Recruiting
25 enrolled